Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




A Way to Increase Kidney Transplant Recipients

By HospiMedica staff writers
Posted on 23 Aug 2006
A new strategy could nearly double the number of recipients who would benefit from living, nondirected (LND) kidney donations and improve transplant outcomes, according to a new study.

Currently, three models exist for choosing recipients of LND donor kidneys in the United States: transplanting into the healthiest patients on the transplant waiting list, administered by the United Network of Organ Sharing (UNOS, Richmond,VA, USA), who are the most likely to have successful outcomes; donation to patients at greatest need, which would be most likely to yield poor transplant outcomes; or giving the organ to the patients at the top of the transplant waiting list regardless of need or expected outcome.

Under the new strategy, called the "domino-paired donation” model, developed by investigators at the Johns Hopkins University School of Medicine (Baltimore, MD, USA), the LND donor's gift is allocated to a combined pool of incompatible donor-patient pairs, initiating a chain of matches. More...
First, the LND donor's kidney is matched to a recipient who has a willing but incompatible donor. The recipient's incompatible donor can, in turn, agree to give a kidney to the next compatible patient on the transplant waiting list, which could lead to a cascade of donor-recipient matches, producing a domino effect.

The investigators developed an optimized algorithm, in which they simulated the number of transplants that could occur in the domino-paired donation model, and compared that with the actual number of transplants that occurred in the United States using LND donor kidneys. Their results show that the domino-paired donation model would result in 583 transplants, instead of the 302 that have actually taken place. The study was reported in the July 29, 2006, issue of The Lancet.

The investigators, led by Dr. Robert A. Montgomery of Johns Hopkins, believe that this model will gain wide acceptance because it would be an ethical way to increase the chances of a good outcome. Furthermore, this tactic would help patients who have the greatest difficulty in being matched due to their blood type or human leukocyte antigen (HLA) sensitization, and thus have to wait longer for a suitable kidney.



Related Links:
Johns Hopkins University School of Medicine
United Network of Organ Sharing

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.